InvestorsHub Logo
Followers 68
Posts 7294
Boards Moderated 0
Alias Born 03/06/2016

Re: nidan7500 post# 423212

Monday, 07/17/2023 10:56:34 AM

Monday, July 17, 2023 10:56:34 AM

Post# of 459845
CHECK THIS OUT...

Alnylam Says Single Injection Of RNAi Therapy Cuts Alzheimer's-Linked Proteins By 65%, Stock Soars
BENZINGA 10:18 AM ET 7/17/2023
Symbol Last Price Change
ALNY 213.24down +16.14 (+8.1887%)
REGN 725.23up +6.71 (+0.9339%)
QUOTES AS OF 10:55:10 AM ET 07/17/2023

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) announced updated interim results for the ongoing single ascending dose portion of the Phase 1 study of ALN-APP for Alzheimer's disease and cerebral amyloid angiopathy (CAA).

ALN-APP is an investigational RNAi therapeutic to demonstrate gene silencing in the human brain under development in collaboration with Regeneron
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News